Tristel PLC
LSE:TSTL

Watchlist Manager
Tristel PLC Logo
Tristel PLC
LSE:TSTL
Watchlist
Price: 425 GBX -1.16% Market Closed
Market Cap: 202.7m GBX
Have any thoughts about
Tristel PLC?
Write Note

Tristel PLC
Investor Relations

Tristel Plc engages in the design, development, manufacture, and sale of infection control, contamination control and hygiene products. The company is headquartered in Snailwell, Cambridgeshire and currently employs 189 full-time employees. The company went IPO on 2005-06-01. The Company’s technology is a chlorine dioxide formulation used by hospitals for the high-level disinfection of medical devices and the sporicidal disinfection of environmental surfaces. The Company’s segments include Hospital medical device decontamination and Hospital environmental surface disinfection. The firm manufactures and sells medical device decontamination products that are used primarily for infection control in hospitals. The firm also manufactures and sells hospital environmental surface disinfection products. The Tristel brand offers airway management, cardiology, ear, nose and throat, ophthalmology, endoscopy, phlebotomy, surfaces, ultrasound, urology, and women's health. The Crystel brand offers pharmaceutical, cosmetic and toiletry (PCT), cleanroom disinfectants and laboratory disinfectants. The company markets its products under the Tristel, Anistel, and Crystel brands.

Show more

Earnings Calls

No Earnings Calls Available

Management

Ms. Elizabeth A. Dixon
CFO & Executive Director
No Bio Available
Mr. Paul Christopher Swinney
Executive Director
No Bio Available
Mr. Matthew G. Sassone
CEO & Director
No Bio Available
Ms. Heidi A. Allard
UK Finance Director, Global Financial Controller & Company Secretary
No Bio Available

Contacts

Address
CAMBRIDGESHIRE
Snailwell
Lynx Business Park,Fordham Road
Contacts
+441638721500.0
www.tristel.com